Keyphrases
Repurposing
100%
Anticancer Drugs
100%
Cancer Therapy
100%
Drug Development
100%
Predictive Biomarker
66%
Anticancer Activity
66%
Attrition Rate
33%
Causes of Mortality
33%
Response Rate
33%
Early Diagnosis
33%
Topoisomerase Inhibitors
33%
Phase II Clinical Trial
33%
Clinical Implementation
33%
Overall Survival
33%
Topoisomerase
33%
Patient Cohort
33%
Medicine and Dentistry
Biological Marker
100%
Antiinfective Agent
100%
Cancer Therapy
100%
Malignant Neoplasm
100%
Anticarcinogen
60%
Antineoplastic Activity
40%
Oncology
20%
Topoisomerase
20%
Phase II Trials
20%
Overall Survival
20%
Side Effect
20%
Chemotherapy
20%
Early Diagnosis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Development
100%
Malignant Neoplasm
100%
Antiinfective Agent
100%
Repurposing
100%
Biological Marker
100%
Anticarcinogen
33%
DNA Topoisomerase Inhibitor
11%
Phase II Trials
11%
DNA Topoisomerase
11%
Side Effect
11%
Overall Survival
11%